• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DDC Extends Bitcoin Accumulation Program into Fifth Consecutive Week

By: DDC Enterprise Limited via Business Wire
February 11, 2026 at 08:12 AM EST
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

DDC Enterprise Limited (NYSEAMERICAN: DDC) (“DDC” or the “Company”), a global Asian food platform and digital asset treasury company, today announced the acquisition of 100 Bitcoin (“BTC”). This latest purchase marks the fifth consecutive week of BTC acquisitions and brings the Company’s total Bitcoin holdings to 1988.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211709632/en/

DDC Now Holds 1,988 BTC

DDC Now Holds 1,988 BTC

The transaction was executed following a recent pullback in BTC prices. The Company’s activity remains guided by its established treasury parameters, with an emphasis on position sizing, liquidity, and balance sheet strength rather than short-term price dynamics.

Bitcoin Purchase Highlights

  • BTC Acquired: 100 BTC
  • Total Bitcoin Holdings: 1988 BTC
  • Average Cost per Bitcoin Holding: $85,756
  • BTC Yield (Year-to-Date): 40%
  • BTC per 1,000 Shares: 0.055648 BTC per 1,000 DDC shares

“Our long-term execution framework is deliberately designed to be insensitive to day-to-day market sentiment,” said Norma Chu, Founder, Chairwoman, and Chief Executive Officer of DDC. “We apply clear guardrails and oversight to our Bitcoin activity so that each transaction fits within a broader, durable capital structure plan.”

The Company’s treasury strategy remains centered on disciplined execution, governance-led decision-making, and transparency in capital allocation. DDC maintains its view of Bitcoin as a scarce, long-duration asset that can enhance treasury resilience against fiat currency debasement and support balance sheet diversification across macroeconomic environments.

About DDC Enterprise Limited

DDC Enterprise Limited (NYSEAMERICAN: DDC) is participating proactively in the corporate Bitcoin treasury evolution while maintaining its foundation as a leading global Asian food platform. The Company has strategically positioned Bitcoin as a core reserve asset while continuing to expand its portfolio of culinary brands. DDC is at the forefront of public companies integrating Bitcoin into their financial architecture. For more information, visit www.ddc.xyz.

Caution Regarding Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. Examples of forward-looking statements include those related to business prospects, accumulation of Bitcoin, the Company and its management’s view of market conditions and outlook, and the Company’s goals, strategy and future activity. These statements are subject to uncertainties and risks including, but not limited to, the risk factors discussed in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 20-F, 6-K and other reports filed with the Securities and Exchange Commission (“SEC”) and available at www.sec.gov. It is also inherent in forward-looking statements for there to be risks, uncertainties and other factors beyond the Company’s ability to predict or control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260211709632/en/

Contacts

Media & Investor Contacts

DDC Investor Relations

Orange Group | Yujia Zhai

ddc@orangegroupadvisors.com

DDC Press and Media

pr@ddc.xyz

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference ↗
Today 1:02 EDT
Via MarketBeat
Topics Artificial Intelligence ETFs
Tickers AMGN
News headline image
Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End ↗
Today 0:02 EDT
Via MarketBeat
Tickers ALVO
News headline image
Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial ↗
June 04, 2026
Via MarketBeat
Tickers ALT
News headline image
Align Technology CFO: Global Growth, DSOs Offset North America Demand Pressure ↗
June 04, 2026
Via MarketBeat
Topics Earnings Economy
Tickers ALGN
News headline image
Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment ↗
June 04, 2026
Via MarketBeat
Tickers ALDX

Recent Quotes

View More
Symbol Price Change (%)
AMZN  253.79
+3.77 (1.51%)
AAPL  311.23
+0.97 (0.31%)
AMD  523.20
-19.32 (-3.56%)
BAC  54.17
+1.77 (3.38%)
GOOG  369.27
+13.59 (3.82%)
META  627.57
+4.59 (0.74%)
MSFT  428.05
+0.71 (0.17%)
NVDA  218.66
+3.91 (1.82%)
ORCL  236.34
+6.01 (2.61%)
TSLA  418.45
-5.25 (-1.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap